Sector News

Lilly appoints SVP of Corporate Affairs and Communications

May 10, 2017
Life sciences

Eli Lilly and Company announced today that Leigh Ann Pusey will be joining Lilly as senior vice president of corporate affairs and communications, effective June 12, 2017.

She will be a member of Lilly’s executive committee reporting directly to president and chief executive officer, David A. Ricks.

Pusey currently serves as president and CEO of the American Insurance Association (AIA), an insurance industry trade association representing more than 300 insurers that provide property and casualty insurance in the United States. She joined AIA in December 1996 and was promoted to president and CEO in February 2009. Pusey is consistently recognized by The Hill as one of the top lobbyists in Washington, D.C. and in 2012 she was named by National Journal as one of the 25 “Most Influential Women in Washington.”

“Leigh Ann brings a wealth of public affairs leadership experience to Lilly and at a particularly important time for our industry,” said Ricks. “Her ability to convene conversations and drive proactive policy solutions will be critical in our efforts to promote and sustain medical innovation so patients and the health care system benefit from a new era of medicine.”

Pusey serves in various capacities for a number of organizations, including as a member of the U.S. Chamber of Commerce’s Committee of 100, and board member of the Insurance Institute for Highway Safety. Prior to joining AIA, Pusey had been the deputy assistant to President George H.W. Bush for the White House Office of Public Liaison and deputy director of communications for the Republican National Committee. Pusey is a graduate of Samford University in Birmingham, Alabama. She currently resides in Alexandria, Virginia, with her husband and their two children.

Source: Eli Lilly and Company

Related News

February 21, 2021

Sanofi invests in health tech firm Novadiscovery, boosting trial simulation platform and COVID-19 work

Life sciences

Novadiscovery uses its so-called JINKO platform that runs disease models on virtual patients to support decision-making and de-risk clinical development.

February 21, 2021

Gilead lets local HIV community groups take the lead with $3M grant

Life sciences

The pharma is pledging $3.2 million over two years to the Human Rights Campaign, the largest lesbian, gay, bisexual, transgender and queer (LGBTQ+) civil rights organization in the U.S.

February 21, 2021

Biotech company funds research project on diversity

Life sciences

In collaboration with Genmab, a new anthropological postdoc project at the Department of Anthropology will now explore and help develop the company’s efforts to ensure a diverse and inclusive workplace.

Send this to a friend